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Abstract 
The mechanism behind the adjuvant effect of aluminium salts is poorly understood 
notwithstanding that aluminium salts have been used for decades in clinical vaccines. 
In an aqueous environment and at a nearly neutral pH, the aluminium salts form 
particulate aggregates and one plausible explanation of the lack of information 
regarding the mechanisms could be the absence of an efficient method of tracking 
phagocytosed aluminium adjuvants and thereby the intracellular location of the 
adjuvant.  
 
In this paper we want to report upon the use of lumogallion staining enabling the 
detection of phagocytosed aluminium adjuvants inside viable cells. Including micro 
molar concentrations of lumogallion in the culture medium resulted in a strong 
fluorescence signal from cells that had phagocytosed the aluminium adjuvant. The 
fluorescence appeared as spots in the cytoplasm and by confocal microscopy and co-
staining with probes presenting fluorescence in the far-red region of the spectrum, 
aluminium adjuvants could to a certain extent be identified as localized in acidic 
vesicles i.e. lysosomes.  
 
Staining and detection of intracellular aluminium adjuvants was not only achieved by 
diffusion of lumogallion into the cytoplasm and thereby highlighting the presence of 
the adjuvant, but could also be achieved by pre-staining the aluminium adjuvant prior 
to incubation with cells. Pre-staining of aluminium adjuvants resulted in bright 
fluorescent particulate aggregates that remained fluorescent for weeks and with only a 
minor reduction of fluorescence upon extensive washing or incubation with cells. 
Both aluminium oxyhydroxide and aluminium hydroxyphosphate, two of the most 
commonly used aluminium adjuvants in clinical vaccines, could be pre-stained with 
lumogallion and were easily tracked intracellularly after incubation with 
phagocytosing cells. 
 
Staining of viable cells using lumogallion will be a useful method in investigations of 
the mechanisms behind aluminium adjuvants’ differentiation of antigen-presenting 
cells into inflammatory cells. Information will be gained regarding the phagosomal 
pathways and the events inside the phagosomes, and thereby the ultimate fate of 
phagocytosed aluminium adjuvants could be resolved. 
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1. Introduction 
Aluminium based adjuvants in the form of aluminium salts have been used in 
pharmaceutical vaccine formulations for many decades. The aluminium adjuvants are 
dispersed in aqueous solvents at circumneutral pH where the aluminium salts form 
particles and aggregates in the nm to μm range. In spite of their extensive use a clear 
mechanistic understanding of how aluminium salts potentiate the induction of an 
immune response is still missing (Exley et al., 2010). Adsorption of antigens onto 
aggregates of the adjuvant and their subsequent release at the inoculation site has long 
been recognized as a possible modus operandi of the adjuvant (Lindblad, 2004). One 
alternative mechanism could be the induction of an inflammatory response by 
aluminium salts and indeed injection of aluminium adjuvants results in cell injury and 
a sterile inflammation (Rock et al., 2010). Cell injury at the injection site triggers the 
release of danger associated molecular patterns (DAMPs) and an infiltration of 
inflammatory cells together with increased levels of relevant chemokines has been 
shown at the inoculation site (Lu et al., 2013). Furthermore, an inflammatory response 
may also be induced by the assembly and activation of the Nalp3 inflammasome by 
antigen presenting cells (APCs) after phagocytosis of aluminium adjuvants, leading to 
the release of IL-1β and IL-18 (Hornung et al., 2008, Eisenbarth et al., 2008, Marrack 
et al., 2009). Considering the efficiency and continued use of aluminium adjuvants, 
experimental information concerning the mechanisms behind the induction of an 
immune response by aluminium adjuvants is surprisingly limited.  
To be able to verify the distribution and action of aluminium salts after injection at 
immunization sites, a robust method allowing for their traceability is warranted. 
Lumogallion has been used as a histological stain to detect the presence of aluminium 
in both plant and mammalian tissues (Silva et al., 2000, Uchumi et al., 1998) and it 
has recently been used to demonstrate the unequivocal presence of aluminium 
adjuvant in a monocytic cell line (Mold et al., 2014). In this paper we intend to report 
upon the use of lumogallion in the staining of living cells after phagocytosis of 
aluminium adjuvants. For this purpose we utilized a monocytic cell line with known 
phagocytizing capacity and a mouse glioma cell line. Staining of living cells by 
lumogallion will open up new possibilities of tracking intracellular aluminium 
adjuvants in viable cells thereby revealing the intracellular fate and pathway(s) of 
aluminium adjuvants after endocytosis. 
.
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2. Materials and Methods 
2.1. Cell lines 
THP-1, (ATCC TIB-202), was obtained from LGC Standards, UK and the GL261 
mouse glioma cells of C57BL/6 origin was kindly provided by Dr. G Safrany, 
Hungary. 
2.2. Materials 
The aluminium adjuvant preparations used herein were Alhydrogel AlO(OH) and 
Adju-Phos AlPO4 purchased from Brenntag Biosector (Fredikssund, Denmark). Al2O3 
60 nm nanoparticles coated with Aluminic Ester and Aluminium Hydroxide 
Nanopowder/Nanoparticles Al(OH)3 10-20 nm were obtained from US Research 
Nanomaterials (Houston Tx, USA).  
Lumogallion (CAS 4386-25-8) came from TCI Europe N.V., Antwerp, Belgium and 
morin hydrate (CAS 654055-01-3) was obtained as a powder from Sigma-Aldrich, St. 
Louis, MO, USA. 
All other reagents were of analytical grade.  
 
2.3. Cell culture 
THP-1 and GL261 cells were cultured in RPMI 1640 medium supplemented with 
10% foetal calf serum of EU grade, (PAA laboratories, Linz, Austria), and 100 g/ml 
of gentamicin (PAA laboratories, Linz, Austria). This medium will be referred to as 
R10. All cells were cultured at 37C in a humidified atmosphere containing 5% CO2 
and the cells were maintained by sub-culturing once every third day.  
 
2.4. Co-culture with aluminium adjuvants and staining of the cells 
Triplicates of THP-1 cells 0.5 x 10
6
 cells per ml were co-cultured in 96 well plates 
with Alhydrogel AlO(OH) adjuvant corresponding to final concentrations of 
aluminium content ranging from 0.8 to 50 μg/mL in a total volume of 200 μl R10 
culture medium during 4 to 16 h (over night) at 37C. Controls consisted of cells 
cultured in R10 medium in the absence of aluminium adjuvant. Lumogallion was then 
added from a stock solution in RPMI 1640 medium to final concentrations of 1.6 to 
20 μM and the cells were further incubated at 37C for various time intervals (30 
minutes up to over night). Controls consisted of cells cultured with and without any 
aluminium adjuvant and without any addition of lumogallion. Specified 
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concentrations of aluminium, lumogallion and incubation periods of each experiment 
are described in the figure legends. After staining, the triplicates from the incubations 
were pooled and centrifuged at 1,000 x g before the cells were re-suspended in 300 μl 
1% (w/v) paraformaldehyde (PFA). Finally the cells were analysed by flow cytometry 
using an Accuri C6 flow cytometer and standard settings. 
In experiments using morin, co-culture with aluminium adjuvant was performed as 
previously described before morin was added to the cells at a final concentration of 
160 μM using a saturated solution of morin in RPMI 1640 medium (800 μM morin) 
as stock solution. Co-culture, washing, fixation and analysis by flow cytometry was 
performed as previously described. 
 
2.5. Pre-staining of aluminium formulations 
2.5.1. Staining of aluminium formulations with lumogallion:  
Various formulations of aluminium adjuvants corresponding to 500, 250, 125 or 62.5 
μg aluminium / ml were incubated with 50 μM lumogallion in a total volume of 1 ml 
R10 medium. The suspensions were incubated at room temperature over night on a 
rocking table and the next day the aluminium particles were collected by 
centrifugation for 10 minutes at 13,000 x g. Finally the particles were re-suspended in 
1 ml R10 medium and the fluorescence of the suspensions was measured by 
spectrofluorometry using excitation 490 nm, emission 580 nm and a cut off filter of 
530 nm. 
2.5.2. Pre-staining of Alhydrogel AlO(OH) adjuvant: 
Alhydrogel AlO(OH) corresponding to 4 mg aluminium / ml was incubated over 
night at room temperature on a rocking table with 50 μM lumogallion in a total 
volume of 1 ml R10 medium. The next day the adjuvant was collected by 
centrifugation for 10 minutes at 13,000 x g. The collected adjuvant was re-suspended 
in 1 ml R10 medium and stored in the refrigerator until further use. 
2.5.3. Release of fluorescence from pre-stained Alhydrogel AlO(OH) upon washing: 
Alhydrogel AlO(OH) corresponding to 4 mg aluminium / ml was incubated over 
night at room temperature on a rocking table with 50 μM lumogallion in a total 
volume of 1 ml R10 medium. The next day the suspension was diluted 20 times with 
R10 medium and 1 ml of the diluted suspension was withdrawn and centrifuged for 
10 minutes at 13,000 x g. The supernatant was collected and the pellet was re-
suspended in a new 1 ml portion of R10 medium. After 5 minutes on a rocking table 
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the sample was once again centrifuged for 10 minutes at 13,000 x g. The supernatant 
was collected again and the pellet re-suspended in a new 1 ml portion of R10 medium 
and placed on a rocking table for 5 minutes before the sample was centrifuged, the 
supernatant collected and the pellet re-suspended in R10 medium. This procedure was 
repeated until 10 supernatants were collected. Finally the fluorescence from all of the 
collected supernatants and a sample corresponding to the suspension obtained after 
the first re-suspension of stained aluminium adjuvant was measured by 
spectrofluorometry using excitation 490 nm, emission 580 nm and a cut off filter of 
530 nm.  
2.5.4. Pre-staining with morin: 
Alhydrogel AlO(OH) corresponding to 0.5 mg aluminium / ml was incubated over 
night at room temperature on a rocking table with 250 μM morin in a total volume of 
1 ml PBS. The next day the adjuvant was collected by centrifugation for 10 minutes at 
13,000 x g. The collected adjuvant was re-suspended in 0.5 ml R10 medium and 
stored in the refrigerator until further use. 
 
2.5.5. Zeta potential analysis: 
Zeta potential analysis was performed using a Zeta Potential/Particle Sizer NICOMP 
380 ZLS, Particle Sizing System, Santa Barbara, CA, USA. Alhydrogel and pre-
stained Alhydrogel were suspended in PBS at a concentration of 2 mg/ml and 
analysed using ZPW388 Application Version 2.00 with the settings; temperature 20 
°C, liquid visco: 1.002, liquid Index of Ref: 1.333, dielectric constant: 78.5 and 
electrode spacing: 0.4 cm. 
 
2.6. Co-culture with pre-stained Alhydrogel AlO(OH). 
Triplicates of THP-1 cells 0.5 x 10
6
 cells per ml were co-cultured in 96 well plates 
with lumogallion or morin pre-stained Alhydrogel AlO(OH) adjuvant corresponding 
to final concentrations of aluminium ranging from 0.8 to 50 μg/ml in a total volume 
of 200 μl R10 culture medium from 4 to 24 h at 37C. Controls were composed of 
cells cultured in R10 medium and cells cultured in the presence of un-stained 
aluminium adjuvant. Specified concentrations of pre-stained aluminium adjuvant and 
incubation periods of each experiment are described in the figure legends. After 
incubation with aluminium adjuvant (pre-stained and un-stained aluminium adjuvant) 
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the triplicates from the incubations were pooled and centrifuged for 5 minutes at 
1,000 x g before the cells were re-suspended in 300 μl 1% (w/v) PFA. Finally the 
cells were analysed by flow cytometry using an Accuri C6 flow cytometer and 
standard settings. 
 
2.7. Microscopy. 
THP-1 cells were co-cultured with aluminium adjuvants or pre-stained adjuvant as 
earlier described and after re-suspension in 1% (w/v) PFA the cell suspensions were 
incubated for 15 minutes at room temperature. The cells were then collected by 
centrifugation for 5 minutes at 1,000 x g and washed twice with 500 μl PBS. Finally 
the cells were re-suspended in a small volume of PBS and mounted on microscope 
slides using ProLong® Gold Antifade Mountant with DAPI (Life Technologies, 
ThermoFisher Scientific, MA USA). After mounting the samples were analysed on a 
Zeiss LSM 780 confocal microscope (Carl Zeiss Microscopy GmbH, Jena, Germany). 
DAPI was excited with the 405 nm laser and emitted light was detected between 401-
529 nm. Lumogallion was either excited with the 561 nm laser and emitted light was 
collected between 585-734 nm or when using dual staining with LysoTracker Deep 
Red excited with the 488 nm laser and emitted light was collected between 553-695 
nm. LysoTracker Deep Red was excited with the 633 nm laser and emitted light was 
collected between 638-759 nm. Z-stack images were obtained at 63x magnification 
and analysed with ZEN 2012 (Carl Zeiss Microscopy GmbH). The samples were also 
analysed by fluorescence microscopy using a light microscope (BX-53, Olympus LRI 
Instruments AB, Lund, Sweden) equipped with a mercury lamp and filters for 
fluorescence (U-MWG, U-MWB, U-MWU). Images were taken in 40x magnification 
using an Olympus Color View digital camera and captured using cellSens Dimension 
imaging software (Olympus). 
GL261 cells were seeded into culture chambers (BD Falcon CultureSlides, uncoated 
from BD Biosciences, MA USA) using 200 μl, 1 x 105 cells/ml in each chamber and 
the cells were allowed to adhere by incubation over night at 37C. The next day 200 
μl aluminium adjuvant ranging from 0.3 to 10 μg/ml was added to the chambers and 
the cells were incubated at 37C during 4 to 16 h (over night). Lumogallion was then 
added to a final concentration of 5 μM and incubated over night at 37C. Controls 
consisted of cells cultured with and without any aluminium adjuvant and without any 
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addition of lumogallion. The cells were then washed with 2 x 400 μl PBS, fixed in 
100 μl 1% (w/v) PFA during 15 minutes at room temperature and washed again with 
2 x 400 μl PBS. Finally the cells were mounted using ProLong® Gold Antifade 
Mountant with DAPI and analysed by confocal or fluorescence microscopy. 
GL261 cells co-cultured with lumogallion pre-stained aluminium adjuvant were after 
incubation washed with 2 x 400 μl PBS, fixed and analysed as described above. 
Specified concentrations of aluminium, lumogallion and incubation periods of each 
experiment are described in the figure legends.   
 
2.8. Flow cytometry and staining with lumogallion and a second fluorochrome 
2.8.1. Staining with lumogallion and a FITC labelled antibody 
Triplicates of THP-1 cells, 0.5 x 10
6
 cells per ml, were co-cultured in a 96 well plate 
with Alhydrogel AlO(OH) adjuvant corresponding to a final concentration of 12.5 μg 
aluminium / ml in a total volume of 200 μl R10 culture medium during 4 hours at 
37C. Lumogallion was added to a final concentration of 5 μM from a stock solution 
in RPMI 1640 medium and the cells were further incubated at 37C over night. 
Controls consisted of cells cultured with and without any aluminium adjuvant and 
without any addition of lumogallion together with addition of a FITC labelled isotype 
control. After staining the triplicates from the incubations were pooled and 
centrifuged at 1,000 x g before the cells were re-suspended in 300 μl PBS containing 
0.1 % (w/v) BSA and 0.1 % (w/v) human IgG. Each pooled sample was then sub-
divided into two samples and incubated on ice for 30 min with FITC-labelled anti 
CD45 or a FITC labelled isotype control (BD Bioscience, San Jose, CA, USA). 
Finally the cells were washed with 500 μl PBS, re-suspended in 400 μl 1% PFA (w/v) 
and analysed by flow cytometry using an Accuri C6 flow cytometer with 70 % 
compensation due to over-flow of lumogallion fluorescence into the green 
fluorescence channel. 
2.8.2. Staining with lumogallion and MitoTracker Deep Red 
Triplicates of THP-1 cells 0.5 x 10
6
 cells per ml were co-cultured in a 96 well plate 
with lumogallion pre-stained Alhydrogel AlO(OH) adjuvant (prepared as described in 
section 2.5.2.) corresponding to a final concentration of 12.5 μg aluminium / ml in a 
total volume of 200 μl R10 culture medium over night at 37C. The next day the 
triplicates from the incubations were pooled and centrifuged for 5 minutes at 1,000 x 
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g before the cells were re-suspended in 300 μl R10 medium containing 5 nM 
MitoTracker Deep Red (Molecular Probes, Life Technologies, ThermoFisher 
Scientific, MA USA). The samples were incubated for 30 minutes at 37C before the 
cells were collected by centrifugation for 5 minutes at 1,000 x g, washed with 400 μl 
PBS and fixed in 400 μl 1% (w/v) PFA. Controls consisted of cells cultured in R10 
medium with and without staining with MitoTracker Deep Red. Finally the cells were 
analysed by flow cytometry using an Accuri C6 flow cytometer with standard settings 
without any compensation of fluorescence over-flow into neither of the FL3 nor FL4 
channels. 
2.8.3. Staining with lumogallion and LysoTracker Deep Red 
GL261 cells, 0.5 x 10
5
 cells per ml, were co-cultured in culture chambers with 2.5 
μg/ml of AlO(OH) during 6 h at 37C in a total volume of 400 μl R10 medium. 
Lumogallion at a concentration of 10 μM was added to the culture and the next day 
the cells were washed with PBS, and further stained with 200 nM LysoTracker Deep 
Red in R10 medium (Molecular Probes, Life Technologies, ThermoFisher Scientific, 
MA USA) for 1 h at 37C. The cells were washed with PBS, fixed in PFA, washed, 
mounted using ProLong® Gold Antifade Mountant with DAPI and analysed by 
confocal microscopy. Controls consisted of cells cultured with and without AlO(OH) 
and with and without staining with lumogallion and MitoTracker Deep Red.  
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3. Results 
3.1. Staining of viable cells 
Fluorescence achieved due to aluminium adjuvants phagocytosed by cells can easily 
be detected by flow cytometry (Fig. 1) or microscopy (Fig. 2) after staining living 
cells with lumogallion. Several hours of incubation with lumogallion was necessary to 
reach a staining equilibrium (Fig. 1C), and importantly, no effect on the viability of 
THP-1 cells was observed by estimating the cell number by counting or by the MTT 
assay after incubation in the presence of 50 μM lumogallion during 24 h (higher 
concentrations or longer incubation times were not investigated). Based on three 
determinations after over night incubation in R10 medium 0.91 x 10
6
 +/- 0.03 x 10
6
 
cells /ml were counted, and after co-culture with 50 μM lumogallion a cell 
concentration of 0.86 x 10
6
 +/- 0.03 x 10
6
 cells /ml was recorded, whereas the MTT 
assay resulted in an absorbance at 600 nm of 1.07 +/- 0.04 in R10 medium and 1.14 
+/- 0.04 in the presence of lumogallion. 
Staining of living cells with lumogallion revealed the internalization of aluminium 
adjuvant particles by phagocytosing cells growing both as suspension cells and as 
adherent cells (Fig. 2). Confocal images clearly showed the aluminium particles to be 
intracellular and that staining was localized in the cytoplasm (Fig. 2A). 
 
3.2. Pre-staining of Aluminium adjuvants 
Aluminium adjuvants can also be pre-labelled with lumogallion before incubation 
with cells. Lumogallion strongly binds to aluminium adjuvant particles although some 
lumogallion was released from the particles upon prolonged washing. The release of 
lumogallion was relatively modest as shown in figure 3A, in which less than 20 % of 
the particle associated fluorescence was dissipated during the second to the tenth re-
suspension. Pre-staining of Alhydrogel affected the z-potential of the aluminium 
aggregates from +13 +/- 4 mV to +3 +/- 2 mV after pre-staining (n=7) and possibly 
also a slight increase in aggregate size. By the use of polystyrene particle size 
standards 3.8 +/- 0.2 % of the Alhydrogel aggregates were larger than 3 μm as 
showed by flow cytometry and forward scatter, whereas in that three independent 
preparations of pre-stained Alhydrogel showed 4.6 +/- 0.8 % of the aggregates larger 
than 3 μm. 
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Pre-staining of the aluminium particles using lumogallion can be done prior to co-
culture with cells in order to detect and trace endocytosed aluminium adjuvant 
particles within the cells (Fig. 4). However, not all aluminium formulations can be 
stained by lumogallion and figure 5 shows the fluorescence obtained from some 
clinical as well as experimental aluminium adjuvants after incubation with 
lumogallion. After incubation and staining, the particles were collected by 
centrifugation and no investigations were done regarding the recovery of aluminium 
adjuvant after centrifugation, although a clearly visible pellet was obtained with all of 
the aluminium preparations. A non-fluorescent white pellet was obtained using Al2O3 
nanoparticles whereas AlO(OH) nanoparticles pellets were clearly yellow as observed 
by direct vision. 
 
3.3. Lumogallion fluorescence 
The lumogallion emission spectrum is extremely broad, ranging from 520 to 650 nm 
with a peak around 580 nm, after excitation at 490 nm. The broad emission spectrum 
makes it difficult to combine lumogallion with other fluorochromes, although by 
using the compensation setting in the flow cytometer software, green fluorescence 
from fluorochromes such as FITC can be analysed in combination with lumogallion 
(Fig. 6). By appropriate use of software compensation (70 – 80 %), the over-flow of 
lumogallion fluorescence into the green fluorescence channel can be attenuated to an 
acceptable level. However, with fluorochromes emitting light in the far-red no over-
flow of lumogallion fluorescence was obtained. Figure 6 shows two examples of 
combining lumogallion with other fluorescent probes; one example shows the 
combination of lumogallion and surface staining using FITC-labelled antibodies (Fig. 
6A). The other example shows the combination with intracellular staining achieved 
by MitoTracker Deep Red (Fig. 6B), a probe that upon diffusion into the cells, 
accumulates in mitochondria and shows fluorescence in the far-red region of the 
spectrum. 
The combination of lumogallion with other fluorescent probes is of utmost 
importance in studies using microscopy to localize intracellular aluminium adjuvant. 
LysoTracker Deep Red is a probe that upon accumulation in acidic compartments 
shows fluorescence in the far-red region of the spectrum and figure 7 clearly shows 
the co-localisation of aluminium particles in lysosomes. No over-flow of lumogallion 
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or LysoTracker Deep Red fluorescence was detected when the cells were stained with 
only one of the probes as controls.  
 
3.4. Staining with morin 
Morin is another commonly used histological stain of aluminium (Lu et al., 2013, 
Eticha et al., 2005, Wen and Wisniewski, 1985) that has a much lower water 
solubility compared to lumogallion. The fluorescence signal from cells containing 
phagocytosed aluminium adjuvant particles was several magnitudes lower when using 
morin, compared to analogous cells stained with lumogallion (Fig. 8). Alhydrogel 
AlO(OH) adjuvant particles can also be pre-stained with morin similarly to 
lumogallion pre-staining, however, compared to staining with free morin, pre-staining 
did not result in any increased fluorescence intensity from the cells (Fig. 8A and B). 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 14 
4. Discussion 
Histological staining using lumogallion was recently described as a method of 
intracellular identification of aluminium adjuvants (Mold et al., 2014). Herein we 
have demonstrated the use of lumogallion in the detection and tracing of aluminium 
adjuvant that is not only restricted to histological sections but can also be used on 
viable cells. In this paper we want to describe the use of lumogallion as a probe for 
staining intracellular aluminium adjuvants of viable cells. Lumogallion can either be 
added directly to the cells and after diffusion stain intracellular aluminium adjuvants, 
or prior to incubation with cells, fluorescently label the aluminium adjuvants and 
thereby creating traceable aluminium formulation in a cellular framework.  
 
The fluorescence signal obtained after staining viable cells containing phagocytosed 
aluminium adjuvant particles was extremely intense. Already at μM concentrations of 
lumogallion during the staining process, a clear signal was obtained by flow 
cytometry (Fig. 1) whereas the diffusion of lumogallion and binding to intracellular 
aluminium needed several hours to reach equilibrium (Fig. 1C). In a staining protocol 
with lumogallion, over-nigh incubation is suggested although a clear and 
unambiguous signal was observed already after less than an hour. In experiments 
where relative fluorescence intensities do not have to be considered, staining can 
therefore be performed in less than an hour. 
 
Lumogallion is strongly adsorbed on particles/aggregates of both AlO(OH) and 
AlPO4, two aluminium salts used in clinical vaccines (Fig 4 and 5), and the 
particles/aggregates can be pre-stained with lumogallion before co-culture with cells 
in order to trace the phagocytosed particles (Fig. 4). Compared to non-stained 
Alhydrogel, no increased cytotoxicity was observed after pre-staining based on 
counting of cells after co-culture of THP-1 with Alhydrogel and pre-stained 
Alhydrogel respectively. 
Some lumogallion was released from the particles upon prolonged washing and the 
release can be hypothesised to correspond to the amount of solubilized Al
3+
 ions 
during the washing procedure. The release of lumogallion was relatively low and less 
than 20 % of the fluorescence was lost as a result of an intense washing procedure, as 
shown in figure 3.  
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Lumogallion has been reported to bind to Al
3+
 ions (Wu et al., 1995). However, based 
on the shown pre-labelling of the adjuvant particles further binding mechanisms as 
deposition of the lumogallion-Al
3+
 complex onto the adjuvant particles has to be 
considered. Nanoparticles often form μm-sized aggregates and these particles, as well 
as particles/aggregates formed by AlO(OH) and AlPO4 used in pharmaceutical 
adjuvants, can be easily collected by centrifugation. However, the size distribution of 
the particles/aggregates will not be the same in the different aluminium formulations 
and this will affect the recovery of particles/aggregates after centrifugation. No 
measures were taken to investigate the recovery of particles/aggregates after pre-
staining with lumogallion and this may to some extent reflect the difference in 
fluorescence intensity between nanoparticles as well as conventional preparations of 
AlO(OH) and AlPO4 shown in figure 5. Nanoparticles of Al2O3 on the other hand 
showed almost no fluorescence after pre-staining although a clearly visible pellet was 
seen after harvesting the particles by centrifugation, indicating the unfeasibility of 
staining Al2O3 particles with lumogallion. The Al2O3 nanoparticles used were coated 
with “Aluminic Ester” by the manufacturer, and further experiments will establish 
whether the coating of the particles affects the possibility to pre-label the Al2O3 
particles or whether it is aluminium oxide as such that has a low interaction with 
lumogallion. 
 
Dual staining with other fluorescent probes is a necessity to ensure appropriate 
intracellular tracking of aluminium adjuvants using lumogallion. The broad emission 
of lumogallion makes it difficult to use other probes emitting fluorescence in the 520 
to 620 nm wavelength range. Only flow cytometers or other instruments where the 
over-flow of emitted light in the different PM-tubes can be compensated provide 
useful information if the secondary emitter overlaps with the lumogallion emission, as 
exemplified by dual staining with a FITC labelled antibody (green fluorescent probes) 
shown in figure 6A. However, no interference was observed in the far-red region of 
the spectrum (Fig. 6B), and probes labelled with far-red emitting fluorochromes are 
well suited to perform dual staining experiments using lumogallion as the aluminium 
probe and this is clearly visualised by the use of the LysoTracker Deep Red probe 
(Fig. 7). 
After phagocytosis, phagosomes containing aluminium adjuvant will mature into 
phagolysosomes having a low pH. Lumogallion and LysoTracker staining will co-
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localise in phagolysosomes containing aluminium adjuvant and co-localisation of 
lumogallion and LysoTracker fluorescence was clearly shown in GL261 cells co-
cultured with aluminium adjuvant (Fig. 7). Not all lumogallion staining co-localised 
with the LysoTracker probe and this will occur in early phagosomes in which the pH 
has not yet decreased. A pH decrease during maturation into phagolysosomes will 
increase the solubility of the aluminium adjuvant, releasing Al
3+
 ions and hydroxide 
ions. Formation of hydroxide will attenuate the pH decrease and lack of co-
localisation with the LysoTracker probe can especially be seen in phagosomes with a 
strong lumogallion staining reflecting phagosomes with a high content of aluminium 
adjuvant hampering the pH decrease. 
 
Morin is another histological stain used to detect aluminium that also can be used to 
detect intracellular aluminium adjuvants in viable cells. Similarly to lumogallion, 
aluminium adjuvants can be detected both by spontaneous diffusion of morin into 
cells or by pre-staining of the adjuvant particles/aggregates before co-culture with the 
cells (Fig. 8). Compared to lumogallion, the morin emission spectrum has a narrow 
bandwidth and it is much easier to combine with other fluorochromes in multiple 
staining of a sample. However, the morin fluorescence is several magnitudes weaker 
than lumogallion, and when using morin to detect intracellular aluminium adjuvants, 
care has to be taken as regards the autofluorescence caused by the cells themselves. 
 
This report has focused on the tracing of aluminium adjuvants in viable cells using 
probes commonly used as histological stains. The staining methods described in this 
paper will make it easy to detect and trace the presence of intracellular aluminium 
adjuvants and will make it possible to elucidate the intracellular pathways and fate of 
endocytosed aluminium adjuvants in the future. 
The rationale to use a phagocytizing cell line in this work is obvious as aluminium is 
used in several vaccines and little is known of the fate of added adjuvant aluminium. 
The GL261 mouse glioma cell line was used to demonstrate that also cells with an 
origin from non-phagocytic cells can take up aluminium and lumogallion. 
Additionally aluminium/lumogallion could be used for labelling of tumour cells and 
in vivo tracking either after isografting or after use of tumour cells in vaccines. 
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The accessibility of instruments such as confocal microscopes and image cytometry, 
integrating flow cytometry and fluorescence microscopy with image analysis, just to 
mention some technologies, have enhanced the information that can be gathered after 
staining viable cells with fluorescent probes. In this paper, we highlight two 
histological stains that also can be used to stain viable cells. Today a diversity of 
histological stains with all kinds of specificities is used as research tools and in 
clinical diagnosis (Bancroft and Gamble, 2007). Several of these stains may also have 
the potential of staining viable cells and thereby make it possible to introduce new 
experimental approaches in cell biology. 
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Legends 
Fig. 1 Staining of THP-1 with lumogallion. 
 A. THP-1 cells were co-cultured with various amounts of Alhydrogel 
AlO(OH) during 24 h and then stained by continuous culture in the presence 
of 10 μM lumogallion during 16 h. The fluorescence from the cells was 
analysed by flow cytometry and the fluorescence intensity was determined as 
the mean fluorescence channel of the cells.  
 B. THP-1 cells were stained with various concentrations of lumogallion after 
co-culture with () or without () AlO(OH), 12.5 μg/ml, during 4 h. After an 
additional 16 h in the presence of various concentrations of lumogallion, the 
fluorescence intensity of the cells was determined by flow cytometry. 
 C. THP-1 cells were stained for various incubation times with lumogallion. 
Cells were co-cultured during 24 h in the presence () or absence () of 
AlO(OH), 12.5 μg/ml. After addition of 10 μM lumogallion, cells were 
withdrawn at various time intervals and analysed by flow cytometry.  
 
Fig.2 Cells co-cultured with Alhydrogel AlO(OH) and stained with lumogallion. 
Cells were co-cultured with either 25 μg/ml (THP-1 cells) or 5 μg/ml (GL261 
cells) of AlO(OH) during 7 h. Lumogallion at a concentration of 5 μM was 
added to the culture and the next day the cells were washed with PBS, fixed in 
PFA and mounted using ProLong® Gold Antifade Reagent. 
 A. Orthogonal projection of a THP-1 cell co-cultured with Alhydrogel 
AlO(OH). The cell was stained with DAPI (blue) and lumogallion (red) to 
visualize intracellular aluminium particles. The image is based on a confocal 
z-stack containing 45 sequential 0.2 µm thick optical sections and shows 
section 23 in the centre of the cell. 
 B. Fluorescent image of the cell line GL261 co-cultured with Alhydrogel 
AlO(OH). 
 
Fig. 3 Release of lumogallion from pre-stained Alhydrogel AlO(OH) particles. 
AlO(OH) was incubated over night with lumogallion and collected by 
centrifugation. Collected AlO(OH) particles were re-suspended in R10 
medium and after 5 min re-centrifuged. Re-suspension and centrifugation 
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were repeated 10 times, each time the supernatants were collected and their 
fluorescence was determined. The figure shows the fluorescence in the 
supernatant after clearance of particles/aggregates after each washing step (). 
The figure also shows the fluorescence associated with dispersed adjuvant 
particles after the first re-suspension corresponding to 476 RFU (). 
 
Fig.4 Cells co-cultured with pre-stained Alhydrogel AlO(OH).  
 A. THP-1 cells were co-cultured during 4 h () or 24 h () with various 
concentrations of AlO(OH) pre-stained with lumogallion. The cells were 
harvested and the mean fluorescence intensity of the cells was determined by 
flow cytometry. 
B. Fluorescence microscope image of GL261 cells co-cultured with 5 μg/ml 
pre-stained AlO(OH) over night before the cells were washed with PBS, fixed 
in PFA and mounted using ProLong® Gold Antifade Reagent. To the right; 
cells cultured in R10 medium. 
   
Fig.5 Pre-staining of aluminium formulations with lumogallion. 
 Aluminium preparations ranging from 62.5 to 500 μg/ml were incubated over 
night with 50 μM lumogallion in R10 medium. The next day the particles were 
harvested, the pellets were re-suspended in 1 ml R10 medium and their 
fluorescence was measured using an excitation wavelength of 490 nm and an 
emission wavelength of 580 nm. Alhydrogel AlO(OH) light grey, AlPO4 
medium grey, AlO(OH) nanoparticles dark grey and Al2O3 nanoparticles 
black.   
 
Fig. 6 Flow cytometry of cells stained with both lumogallion and a second 
fluorescent probe. 
 A. THP-1 cells were co-cultured with Alhydrogel AlO(OH), 12.5 μg/ml 
during 4 h and stained over night with 5 μM lumogallion. The next day the 
cells were harvested, washed, re-suspended in PBS containing 0.1 % BSA, 0.1 
% h-IgG, stained with FITC labelled anti CD45 and analysed by flow 
cytometry using 70 % compensation of overflow of lumogallion fluorescence 
into the green PM-tube.  
a). Cells co-cultured with AlO(OH), and stained with lumogallion.  
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b). Cells co-cultured with AlO(OH), and stained with lumogallion and anti 
CD45-FITC.  
c). Cells co-cultured with AlO(OH), and stained with a FITC labelled isotype 
control antibody.  
d). Cells co-cultured with AlO(OH), and stained with anti CD45-FITC 
B. THP-1 cells were co-cultured with Alhydrogel AlO(OH) particles (12.5 
μg/ml) pre-stained with lumogallion over night. The next day 5 nM of the 
mitochondrial probe MitoTracker Deep Red was added to the cells. After 30 
min the cells were harvested, washed with PBS, fixed in 0.1 % PFA and 
analysed by flow cytometry using no compensation on the PM-tubes. 
a). Cells cultured in R10 medium.  
b). Cells cultured in R10 medium and stained with MitoTracker Deep Red.  
c). Cells co-cultured with pre-stained Alhydrogel AlO(OH) particles and 
stained with MitoTracker Deep Red 
 
Fig. 7 GL261 cells co-cultured with Alhydrogel AlO(OH) and stained with 
lumogallion and LysoTracker Deep Red. 
Cells were co-cultured with 2.5 μg/ml of AlO(OH) during 7 h. Lumogallion at 
a concentration of 5 μM was added to the culture and the next day the cells 
were washed and stained with 100 nM LysoTracker Deep Red. Finally the 
cells were washed with PBS, fixed in PFA and mounted using ProLong® 
Gold Antifade Reagent. 
 Orthogonal projection of a GL261 cell co-cultured with Alhydrogel AlO(OH). 
The cell was stained with DAPI (blue), lumogallion (green) and LysoTracker 
Deep Red (red) to visualize nucleus, intracellular aluminium particles and 
lysosomes, respectively. The images are based on a confocal z-stack 
containing 20 sequential 0.45 µm thick optical sections and shows section 10 
in the centre of the cell. 
 
Fig. 8 Flow cytometry of THP-1 cells stained with morin or lumogallion after co-
culture with or without Alhydrogel AlO(OH).  
A. Cells co-cultured with Alhydrogel AlO(OH), 12.5 μg/ml, (grey histogram) 
and stained with 160 μM morin, cells cultured in R10 and stained with 160 
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μM morin (light grey histogram) and non-stained cells co-cultured with 
AlO(OH) (black histogram). 
B. Cells co-cultured with Alhydrogel AlO(OH) particles pre-stained with 
morin, 50 μg/ml, (grey histogram) and cells cultured in R10 medium 
(black histogram). 
C. Cells co-cultured with Alhydrogel AlO(OH), 12.5 μg/ml, (grey histogram) 
and stained with 5 μM lumogallion, cells cultured in R10 and stained with 
5 μM lumogallion (light grey histogram) and non-stained cells co-cultured 
with AlO(OH) (black histogram). 
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Graphical abstract 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 36 
Highlights 
 
 Fluorescent staining of aluminium adjuvants by lumogallion. 
 Tracking of phagocytosed and intracellular identification of 
aluminium adjuvant in viable cells. 
 Fluorescent labelling of aluminium adjuvants used in clinical 
vaccines. 
